Announcements Trials
Browse Landscape

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Breast Neoplasms 4Triple Negative Breast Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Sentinel Lymph Node Biopsy (SLNB) 1Rhabdomyosarcoma 1Rectal Neoplasms 1Mouth Neoplasms 1Melanoma 1HIV Infections 1FIGO Grade 1 Endometrial Endometrioid Adenocarcinoma 1Anus Neoplasms 1

Interventions

ipatasertib 1Specimen Handling 1Sentinel Lymph Node Biopsy 1Ovariectomy 1Megestrol Acetate 1Magnetic Resonance Spectroscopy 1Hysterectomy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
FIGO Grade 1 Endometrial Endometrioid Adenocarcinoma × Sentinel Lymph Node Biopsy × 90 days × Clear all
NCT04604613 2026-03-09

Prediction of Recurrence Among Low Risk Endometrial Cancer Patients

M.D. Anderson Cancer Center

Active not recruiting
518 enrolled
Gynecologic

FIGO Grade 1 Endometrial Endometrioid Adenocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡